ctrl K

Watchlist Price Alert

Virios Therapeutics Inc. (VIRI)

NASDAQ: VIRI · Real-Time Price · USD

0.15

0.01 (8.77%)

At close: Oct 08, 2024, 8:00 PM

Virios Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-5.45M	-12.32M	-15.64M	-10.01M	-2.18M	-1.96M
Interest Income	150.9K	67.47K	5.67K	384.22	295.13	n/a
Pretax Income	-5.3M	-12.25M	-15.96M	-10.35M	-2.47M	-2.11M
Net Income	-5.3M	-12.18M	-15.96M	-10.35M	-2.77M	-2.11M
Selling & General & Admin	3.72M	4.25M	4.85M	9.81M	1.34M	1.11M
Research & Development	1.73M	8.07M	10.8M	194.01K	836.17K	854.11K
Other Expenses	n/a	67.47K	-319.33K	-341K	n/a	6.00
Operating Expenses	5.45M	12.32M	15.64M	10.01M	2.18M	1.96M
Interest Expense	n/a	n/a	5.67K	384.22K	295.13K	152.1K
Selling & Marketing Expenses	3.72M	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	5.45M	12.32M	15.64M	10.01M	2.18M	1.96M
Income Tax Expense	-5.45K	-67.47K	-15.64K	-10.01K	295.13K	152.1K
Shares Outstanding (Basic)	18.78M	11.07M	8.33M	8.31M	8.28M	4.83M
Shares Outstanding (Diluted)	18.78M	11.07M	8.33M	8.31M	8.28M	4.83M
EPS (Basic)	-0.28	-1.1	-1.92	-1.25	-0.33	-0.44
EPS (Diluted)	-0.28	-1.1	-1.92	-1.25	-0.33	-0.44
EBITDA	150.9K	-12.32M	-15.64M	-10.01M	-295.13K	-152.1K
EBIT	n/a	n/a	-15.95M	-9.96M	n/a	-1.96M
Depreciation & Amortization	5.45M	12.32M	15.64M	10.01M	2.18M	1.96M